| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Lantheus Holdings (NASDAQ:LNTH) narrows FY2025 Adj EPS guidance from $5.50-$5.70 to $5.50-$5.65 vs $5.63 analyst estimate. Rais...
Lantheus Holdings, Inc. (the "Company") (NASDAQ:LNTH), the leading radiopharmaceutical-focused company committed to ena...
Lantheus Holdings (NASDAQ:LNTH) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $1....
Lantheus Holdings, Inc. ("Lantheus") (NASDAQ:LNTH), the leading radiopharmaceutical-focused company committed to enabli...
Goldman Sachs analyst Paul Choi downgrades Lantheus Holdings (NASDAQ:LNTH) from Buy to Neutral and lowers the price target f...